Which EDE-Q items are structurally relevant in borderline personality disorder? An exploratory graph analysis
Abstract
Background: Borderline personality disorder (BPD) frequently co-occurs with eating disorders (EDs). Despite this clinical relevance, the dimensional structure of commonly used assessment instruments, such as the Eating Disorder Examination Questionnaire (EDE-Q), has not been sufficiently examined in BPD populations. Previous research suggests that the original four-factor structure of the EDE-Q may not be stable across different populations.
Methods: This study examined the structure of the EDE-Q in a clinical sample of individuals with BPD (N = 73) using Exploratory Graph Analysis (EGA), a network-based approach to dimensionality assessment. Dimensionality and item stability were evaluated using nonparametric bootstrapping. Robustness was assessed via sensitivity analyses, including median imputation, variation of the regularization parameter, comparison of community detection algorithms, and leave-one-item-out procedures.
Results: After iterative item reduction, a three-dimensional solution emerged, comprising 13 items. The identified dimensions reflected (1) Restraint, (2) Cognitive-Interpersonal Eating Concerns, and (3) Body Dissatisfaction. The final solution demonstrated high robustness across all sensitivity analyses, with identical dimensional structures and item assignments under multiple conditions.
Conclusions: The findings suggest that the original four-factor structure of the EDE-Q may not fully generalize to individuals with BPD. Several aspects of the…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.